Literature DB >> 21831499

Eosinophilic pleural effusion: incidence, etiology and prognostic significance.

Lucía Ferreiro1, Esther San José, Francisco Javier González-Barcala, José Manuel Alvarez-Dobaño, Antonio Golpe, Francisco Gude, Christian Anchorena, Marco F Pereyra, Carlos Zamarrón, Luis Valdés.   

Abstract

INTRODUCTION: Eosinophilic pleural effusion (EPE) has been associated with less risk for malignancy with a potential causal relationship with the presence of air and/or blood in the pleural space. However, these theories have fallen by the wayside in the light of recent publications.
OBJECTIVES: To determine the incidence and etiology of EPE and to observe whether the eosinophils in the pleural liquid (PL) increase in successive thoracocenteses. PATIENTS AND METHODS: We analyzed 730 PL samples from 605 patients hospitalized between January 2004 and December 2010.
RESULTS: We identified 55 samples with EPE from 50 patients (8.3%). The most frequent etiologies of EPE were: unknown (36%) and neoplasm (30%). There were no significant differences in the incidence of neoplasms between the non-eosinophilic pleural effusions (non-EPE) (25.9%) and the EPE (30%) (p=0.533). One hundred patients (16.5%) underwent a second thoracocentesis. Out of the 9 who had EPE in the first, 6 maintained EPE in the second. Out of the 91 with non-EPE in the first thoracocentesis, 8 (8.8%) had EPE in the repeat thoracocentesis. The percentage of eosinophils did not increase in the successive thoracocenteses (p=0.427). In the EPE, a significant correlation was found between the number of hematites and eosinophils in the PL (r=0.563; p=0.000).
CONCLUSIONS: An EPE cannot be considered an indicator of benignancy, therefore it should be studied as any other pleural effusion. The number of eosinophils does not seem to increase with the of repetition of thoracocentesis and, lastly, the presence of blood in the PL could explain the existence of EPE.
Copyright © 2011 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21831499     DOI: 10.1016/j.arbres.2011.06.011

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

Review 1.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

Review 2.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

3.  Efficacy of ultrasound-guided thoracentesis catheter drainage for pleural effusion.

Authors:  Weitian Cao; Yi Wang; Ningming Zhou; Bing Xu
Journal:  Oncol Lett       Date:  2016-10-12       Impact factor: 2.967

4.  Intrapleural corticosteroid injection in eosinophilic pleural effusion associated with undifferentiated connective tissue disease.

Authors:  Eunjung Kim; Changhwan Kim; Bokyung Yang; Mihee Kim; Jingu Kang; Jiun Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-10-29

5.  Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience.

Authors:  Weizhan Luo; Yunxiang Zeng; Panxiao Shen; Jianxing He; Jinlin Wang
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

6.  Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study.

Authors:  Minfang Li; Yunxiang Zeng; Sheng Chen; Jinlin Wang; Yaqing Li; Dan Jia
Journal:  BMC Pulm Med       Date:  2021-12-06       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.